Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 708 (USA) (Dr. Kim)
· consented 2013-01-25
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-02 (study day 68.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild APPLICATION SITE SWELLING — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-02 (study day 68.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-08 (study day 104.0); relationship: REMOTE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.